Literature DB >> 9226056

The effects of topical nasal steroids on rat respiratory mucosa in vivo, with special reference to benzalkonium chloride.

O H Berg1, K Lie, S K Steinsvåg.   

Abstract

Fifty rats were treated with topical nasal steroids with and without the preservative benzalkonium chloride in their right nostril twice daily for 21 days, while the left nostrils were exposed to 0.9% NaCl. By cutting the noses serially in frontal sections, the structure of the mucosal lining of all parts of the nose could be investigated. Areas with squamous cell metaplasia were observed in all nostrils exposed to topical steroids containing benzalkonium chloride. Such alterations were not observed in any nasal cavities exposed to the topical nasal steroid without the preservative or to 0.9% NaCl. In conclusion, benzalkonium chloride appears to be potentially toxic to the mucosa in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9226056     DOI: 10.1111/j.1398-9995.1997.tb01041.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  8 in total

Review 1.  Nasoseptal Perforation: from Etiology to Treatment.

Authors:  Carla Pereira; Alfonso Santamaría; Cristobal Langdon; Mauricio López-Chacón; José Hernández-Rodríguez; Isam Alobid
Journal:  Curr Allergy Asthma Rep       Date:  2018-02-05       Impact factor: 4.806

2.  The mucosal toxicity of different benzalkonium chloride analogues evaluated with an alternative test using slugs.

Authors:  E Adriaens; K Dierckens; T G Bauters; H J Nelis; F van Goethem; P Vanparys; J P Remon
Journal:  Pharm Res       Date:  2001-07       Impact factor: 4.200

3.  [Dexpanthenol nasal spray in comparison to dexpanthenol nasal ointment. A prospective, randomised, open, cross-over study to compare nasal mucociliary clearance].

Authors:  T Verse; N Klöcker; F Riedel; W Pirsig; M O Scheithauer
Journal:  HNO       Date:  2004-07       Impact factor: 1.284

4.  The effects on mucociliary clearance of prednisone associated with bronchial section.

Authors:  Karina Andrighetti de Oliveira Braga; Natalia Aparecida Nepomuceno; Aristides Tadeu Correia; Fabio Biscegli Jatene; Paulo Manuel Pêgo-Fernandes
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

Review 5.  Intranasal drug delivery: opportunities and toxicologic challenges during drug development.

Authors:  Lea-Adriana Keller; Olivia Merkel; Andreas Popp
Journal:  Drug Deliv Transl Res       Date:  2021-01-25       Impact factor: 4.617

6.  Xylometazoline nasal drops induced anaphylaxis: An atypical perioperative complication.

Authors:  Rudrashish Haldar; Sukhminderjit Singh Bajwa; Jasleen Kaur
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2017 Jul-Sep

7.  Nasal Mucosal Dysplasia Induced by Topical Corticosteroids with Benzalkonium Chloride.

Authors:  Funda Tamer; Erol Koc; Taylan Gun; Can Ergin
Journal:  Indian Dermatol Online J       Date:  2018 Mar-Apr

Review 8.  Objective monitoring of nasal patency and nasal physiology in rhinitis.

Authors:  Robert A Nathan; Ron Eccles; Peter H Howarth; Sverre K Steinsvåg; Alkis Togias
Journal:  J Allergy Clin Immunol       Date:  2005-03       Impact factor: 10.793

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.